Literature DB >> 26455690

Do antipsychotics cause hip fractures? Promise and pitfalls of big data.

John M Davis1, Christopher E Ramsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26455690      PMCID： PMC9454380          DOI： 10.4088/JCP.14com09551

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   5.906


× No keyword cloud information.
  11 in total

1.  Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-03-07       Impact factor: 4.507

2.  Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.

Authors:  Chi-Shin Wu; Chia-Ming Chang; Yu-Ting Tsai; Ya-Wen Huang; Hui-Ju Tsai
Journal:  J Clin Psychiatry       Date:  2015-09       Impact factor: 4.384

3.  Reduced relative risk of fractures among users of lithium.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Calcif Tissue Int       Date:  2005-07-14       Impact factor: 4.333

4.  Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability.

Authors:  G de Kuijper; H Evenhuis; R B Minderaa; P J Hoekstra
Journal:  J Intellect Disabil Res       Date:  2012-10-10

Review 5.  A review of the association between antipsychotic use and hyperprolactinaemia.

Authors:  Chris Bushe; Michael Shaw; Robert C Peveler
Journal:  J Psychopharmacol       Date:  2008-03       Impact factor: 4.153

6.  Second-generation antipsychotics and bone turnover in schizophrenia.

Authors:  Kyoji Okita; Nobuhisa Kanahara; Motoi Nishimura; Toshihiko Yoshida; Norio Yasui-Furukori; Tomihisa Niitsu; Taisuke Yoshida; Masatomo Ishikawa; Hiroshi Kimura; Fumio Nomura; Masaomi Iyo
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

7.  The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: findings from a longitudinal observational cohort.

Authors:  Tatsuichiro Takahashi; Hiroyuki Uchida; Majnu John; Jinichi Hirano; Koichiro Watanabe; Masaru Mimura; Christoph U Correll; Taishiro Kishimoto
Journal:  Schizophr Res       Date:  2013-05-11       Impact factor: 4.939

8.  Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis.

Authors:  Holger J Sørensen; Signe O W Jensen; Jimmi Nielsen
Journal:  Eur Neuropsychopharmacol       Date:  2013-05-01       Impact factor: 4.600

9.  Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; T P van Staa; A C G Egberts; H G M Leufkens; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2009-01-21       Impact factor: 4.507

10.  Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis.

Authors:  Christopher E Ramsden; Daisy Zamora; Boonseng Leelarthaepin; Sharon F Majchrzak-Hong; Keturah R Faurot; Chirayath M Suchindran; Amit Ringel; John M Davis; Joseph R Hibbeln
Journal:  BMJ       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.